You are here

Trump to Lawmakers: Deal on PPACA Overhaul Expected “Very Quickly”

President remains optimistic after House debacle

President Trump has told a group of senators that he expects lawmakers will be able to reach a deal on health care, without offering specifics on how they would do it or what had changed since a Republican-backed plan to reform the Patient Protection and Affordable Care Act (PPACA) was withdrawn from a House vote last week because of insufficient support.

“I have no doubt that that’s going to happen very quickly,” Trump said at a bipartisan reception held for senators and their spouses at the White House, according to a Reuters report. “I think it's going to happen because we’ve all been promising––Democrat, Republican––we’ve all been promising that to the American people,” he added.

A Republican bill backed by Trump to overhaul the PPACA was pulled on March 24 after it became apparent that the plan would not receive enough votes to pass. Trump did not mention that failure at the reception, nor did he offer specifics on how he planned to get fractious fellow Republicans to reach a consensus on health care reform.

Last week, House Republican leaders, facing a revolt among conservatives and moderates in their ranks, withdrew the legislation from consideration on the House floor in what was widely seen as a major defeat for Trump.

The bill’s demise was largely due to opposition from members of the conservative House Freedom Caucus, which wanted more-aggressive steps to lower insurance costs and to dismantle federal regulation of insurance products.

Sources: Reuters; March 28, 2017; and The New York Times; March 24, 2017.

Recent Headlines

Study of posted prices finds wild variations and missing data
Potential contamination could lead to supply chain disruptions
Despite older, sicker patients, mortality rate fell by a third in 10 years
Study finds fewer than half of trials followed the law
WHO to meet tomorrow to decide on international public heath emergency declaration
Declining lung cancer mortality helped fuel the progress
Kinase inhibitor targets tumors with a PDGFRA exon 18 mutation
Delayed surgery reduces benefits; premature surgery raises risks
Mortality nearly doubled when patients stopped using their drugs